17.24BMarket Cap-213272P/E (TTM)
24.560High21.860Low4.69MVolume21.950Open21.840Pre Close110.18MTurnover4.58%Turnover RatioLossP/E (Static)734.89MShares33.89052wk High88.53P/B2.40BFloat Cap1.64052wk Low--Dividend TTM102.50MShs Float33.890Historical High--Div YieldTTM12.36%Amplitude0.660Historical Low23.492Avg Price1Lot Size
Summit Therapeutics Stock Forum
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
i will shot this till $15
No comment yet